Cancer glossary
Triple-negative breast cancer: what it means and how it is treated
Triple-negative cancer is a breast cancer subtype without ER, PR and HER2. Why it needs a different approach, why BRCA testing matters and which treatment is used.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
Triple-negative breast cancer is a subtype in which all three targets are negative on IHC: the estrogen receptor (ER), the progesterone receptor (PR) and HER2. It accounts for about 10–15% of breast cancers.
How it appears in your report
- ‘ER 0, PR 0, HER2 0 (or 1+) — triple-negative phenotype’.
- ‘ER-low (1–10%)’ — a borderline situation that often behaves more like triple-negative.
- ‘HER2 1+ / 2+ FISH-negative’ — HER2-low, see HER2-low.
What it means
According to the American Cancer Society, triple-negative cancer is more common in women under 40, in Black women and in carriers of a BRCA1 mutation. It grows and spreads faster and more often comes back in the first years after treatment.
Because hormone therapy and anti-HER2 drugs don't work, chemotherapy is the backbone of treatment. With a tumor over 1–2 cm or involved lymph nodes it usually starts before surgery, together with the immunotherapy drug pembrolizumab. A complete response (pCR) is a strong favorable prognostic sign.
Does it affect treatment
Yes, directly. Everyone with triple-negative cancer should discuss testing for inherited BRCA mutations: it decides PARP inhibitors and the approach for relatives. In metastatic cancer, PD-L1 and HER2-low are checked — for immunotherapy and antibody–drug conjugates.
Questions to ask your doctor
- Will we start with chemotherapy before surgery?
- Do I need pembrolizumab?
- Has a BRCA test been done — and do my relatives need one?
Sources
- Triple-negative Breast Cancer — American Cancer Society
- Pembrolizumab — National Cancer Institute
- Chemotherapy for Breast Cancer — National Cancer Institute
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
